Researchers Uncover New Appetite-Suppressing Ketosis Pathway

Researchers from Stanford and Baylor have uncovered a new metabolic pathway related to ketosis, according to a study published in *Cell*. The pathway involves the compound BHB-Phe, which suppresses appetite through signaling in the brain. This discovery could inform biotech product development for metabolic health and weight management.

- The lead researchers on this study were Dr. Jonathan Z. Long, an Associate Professor of Pathology at Stanford, and Dr. Yong Xu, a Professor of Pediatrics and Nutrition at Baylor College of Medicine. Their labs specialize in the molecular mechanisms of energy balance and the neural control of metabolism. - The key enzyme in this newly discovered pathway is called CNDP2. The same research team previously identified CNDP2 as the enzyme responsible for producing Lac-Phe, a different appetite-suppressing compound generated during exercise. - To confirm their findings, the scientists ran experiments on mice. They showed that injecting BHB-Phe directly into obese mice led to reduced food intake and weight loss. Conversely, mice genetically engineered to lack the CNDP2 enzyme ate more and gained weight when on a ketogenic diet. - This discovery of a new metabolic pathway is a prime example of the work done in biotech product development. Professionals in this field take fundamental scientific discoveries like this one and explore how they can be turned into tangible products, such as new drugs for weight management or diagnostic tests. - A career in computational biology or bioinformatics would involve analyzing the large datasets generated in studies like this. These tech-focused roles use programming and statistical skills to identify patterns in biological data, for instance, by modeling how BHB-Phe interacts with brain receptors or by analyzing the genetic sequences of the CNDP2 enzyme across different populations. - In contrast, a patient-facing role like a physician specializing in endocrinology or a clinical research coordinator would be involved much later. They might, for example, design and run the human clinical trials for a future drug based on BHB-Phe, directly interacting with patients to test its safety and effectiveness. - The educational path for these careers differs significantly. A tech-focused research role typically requires a Ph.D. in a field like computational biology, while a patient-facing medical role requires an M.D. Genetic counselors, who help patients understand their genetic predispositions to metabolic conditions, typically need a master's degree. - While both BHB-Phe and the previously discovered Lac-Phe suppress appetite, the researchers found they activate mostly different sets of neurons in the brain. This suggests the body has multiple, distinct pathways to regulate hunger in response to different metabolic states like ketosis and exercise.

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.